Fewer Companies are Going Public. Here's Why That Matters...

Kathryn Cicoletti |

Private investors (think VCs and private equity firms) as well as government owned funds (think funds that are run by a government) are growing. As they gain assets, companies look to them for investments rather than going to the public market through an initial public offering (where we could then buy the stock).

For companies, raising money from private investors is usually always preferred first. Once that's tapped out, they head to the public markets. Once your company is public, so are your financials.

So getting more money from private investors (vs. issuing stock in your company) inevitably means fewer IPOs.

"Last year, 111 companies went public on US exchanges, raising $24.2 billion, a dollar-volume drop of 33% from the previous year and the lowest dollar volume since 2003, according to Dealogic."

The bad part about this is that the public doesn't get to participate in the potential upside of these stocks. The only people who participate in the upside are the original investors, say, if the company is acquired for a purchase price bigger than the current value.

The good part is you have fewer people (the public) investing in stocks that they don't understand, which never has a good ending.

Some are saying there's a bubble in the private markets. I have no clue.

But who cares.

"The beauty of the VC (private investing) business is you don’t have to be right that often, as long as you are right about something big. Which leads to going out on a limb and taking risks." - AVC.

Originally published in the Ms. Cheat Sheet newsletter. See more from Kathryn Cicoletti at Ms. Cheat Sheet here.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Emerging Growth

Pressure Biosciences Inc

Pressure BioSciences Inc is a biological life sciences research company. It is engaged in the development and commercialization of a platform technology called pressure cycling technology.

Private Markets


Trustify provides trust and safety in both the digital and physical worlds through our vast network of on-demand Private Investigators.By removing the large retainers and high hourly rates that traditional…

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…